Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | thyroid hormone receptor, beta | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | photoreceptor-specific nuclear receptor | thyroid hormone receptor, beta | 461 aa | 414 aa | 24.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.008 | 0.1112 | 0.154 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.008 | 0.1112 | 0.3297 |
Entamoeba histolytica | phosphoglycerate kinase, putative | 0.0189 | 0.3373 | 1 |
Giardia lamblia | Phosphoglycerate kinase | 0.0189 | 0.3373 | 0.5 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0164 | 0.2854 | 0.4258 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.036 | 0.1068 |
Leishmania major | phosphoglycerate kinase C, glycosomal | 0.0189 | 0.3373 | 1 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.008 | 0.1112 | 0.154 |
Echinococcus multilocularis | phosphoglycerate kinase 1 | 0.0189 | 0.3373 | 0.5067 |
Schistosoma mansoni | phosphoglycerate kinase | 0.0189 | 0.3373 | 0.5067 |
Mycobacterium ulcerans | phosphoglycerate kinase | 0.0189 | 0.3373 | 1 |
Wolbachia endosymbiont of Brugia malayi | phosphoglycerate kinase | 0.0189 | 0.3373 | 0.5 |
Trypanosoma cruzi | 3-phosphoglycerate kinase, glycosomal | 0.0069 | 0.0898 | 0.2663 |
Trypanosoma brucei | phosphoglycerate kinase | 0.0189 | 0.3373 | 1 |
Loa Loa (eye worm) | nucleolar RNA-associated protein alpha | 0.0342 | 0.6535 | 1 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.008 | 0.1112 | 0.3297 |
Toxoplasma gondii | phosphoglycerate kinase PGKII | 0.0189 | 0.3373 | 1 |
Loa Loa (eye worm) | beta-lactamase | 0.008 | 0.1112 | 0.154 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.008 | 0.1112 | 0.154 |
Brugia malayi | hypothetical protein | 0.0043 | 0.036 | 0.0723 |
Trypanosoma cruzi | phosphoglycerate kinase, putative | 0.0189 | 0.3373 | 1 |
Trypanosoma cruzi | phosphoglycerate kinase, putative | 0.0069 | 0.0898 | 0.2663 |
Onchocerca volvulus | 0.008 | 0.1112 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.008 | 0.1112 | 0.154 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.036 | 0.1068 |
Trypanosoma brucei | phosphoglycerate kinase | 0.0189 | 0.3373 | 1 |
Treponema pallidum | phosphoglycerate kinase | 0.0189 | 0.3373 | 0.5 |
Toxoplasma gondii | phosphoglycerate kinase PGKI | 0.0189 | 0.3373 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.008 | 0.1112 | 0.154 |
Trypanosoma brucei | phosphoglycerate kinase, putative | 0.0069 | 0.0898 | 0.238 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.008 | 0.1112 | 0.154 |
Loa Loa (eye worm) | hypothetical protein | 0.008 | 0.1112 | 0.154 |
Echinococcus granulosus | phosphoglycerate kinase 1 | 0.0189 | 0.3373 | 0.5067 |
Echinococcus multilocularis | snurportin 1 | 0.0342 | 0.6535 | 1 |
Brugia malayi | Phosphoglycerate kinase | 0.0069 | 0.0898 | 0.238 |
Trypanosoma cruzi | phosphoglycerate kinase, putative | 0.0069 | 0.0898 | 0.2663 |
Brugia malayi | beta-lactamase | 0.008 | 0.1112 | 0.3039 |
Trichomonas vaginalis | esterase, putative | 0.008 | 0.1112 | 0.3297 |
Schistosoma mansoni | phosphoglycerate kinase | 0.0189 | 0.3373 | 0.5067 |
Schistosoma mansoni | thyroid hormone receptor | 0.0164 | 0.2854 | 0.4258 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0152 | 0.2602 | 0.3865 |
Trypanosoma cruzi | phosphoglycerate kinase, putative | 0.0189 | 0.3373 | 1 |
Trichomonas vaginalis | phosphoglycerate kinase, putative | 0.0189 | 0.3373 | 1 |
Plasmodium vivax | phosphoglycerate kinase, putative | 0.0189 | 0.3373 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.036 | 0.0366 |
Loa Loa (eye worm) | hypothetical protein | 0.0189 | 0.3373 | 0.5067 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.036 | 0.1068 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.008 | 0.1112 | 0.154 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.036 | 0.0366 |
Onchocerca volvulus | 0.008 | 0.1112 | 0.5 | |
Trypanosoma cruzi | hypothetical protein, conserved | 0.008 | 0.1112 | 0.3297 |
Chlamydia trachomatis | phosphoglycerate kinase | 0.0189 | 0.3373 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.008 | 0.1112 | 0.154 |
Trichomonas vaginalis | phosphoglycerate kinase, putative | 0.0189 | 0.3373 | 1 |
Brugia malayi | Phosphoglycerate kinase | 0.0189 | 0.3373 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.008 | 0.1112 | 0.3039 |
Trypanosoma brucei | phosphoglycerate kinase | 0.0069 | 0.0898 | 0.238 |
Brugia malayi | beta-lactamase family protein | 0.008 | 0.1112 | 0.3039 |
Plasmodium vivax | hypothetical protein, conserved | 0.008 | 0.1112 | 0.3039 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.008 | 0.1112 | 0.3297 |
Brugia malayi | beta-lactamase family protein | 0.008 | 0.1112 | 0.3039 |
Leishmania major | PAS-domain containing phosphoglycerate kinase, putative | 0.0069 | 0.0898 | 0.2663 |
Trypanosoma cruzi | PAS-domain containing phosphoglycerate kinase, putative | 0.0069 | 0.0898 | 0.2663 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.036 | 0.0366 |
Leishmania major | phosphoglycerate kinase B, cytosolic | 0.0189 | 0.3373 | 1 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.008 | 0.1112 | 0.3039 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.008 | 0.1112 | 0.3297 |
Schistosoma mansoni | hypothetical protein | 0.0152 | 0.2602 | 0.3865 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.008 | 0.1112 | 0.3297 |
Schistosoma mansoni | hypothetical protein | 0.0342 | 0.6535 | 1 |
Plasmodium falciparum | phosphoglycerate kinase | 0.0189 | 0.3373 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.036 | 0.1068 |
Onchocerca volvulus | 0.008 | 0.1112 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.008 | 0.1112 | 0.154 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0152 | 0.2602 | 0.3865 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.036 | 0.0366 |
Echinococcus granulosus | snurportin 1 | 0.0342 | 0.6535 | 1 |
Brugia malayi | RNA, U transporter 1 | 0.0091 | 0.1347 | 0.3761 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.008 | 0.1112 | 0.3297 |
Mycobacterium tuberculosis | Probable phosphoglycerate kinase Pgk | 0.0189 | 0.3373 | 0.2544 |
Leishmania major | hypothetical protein, conserved | 0.008 | 0.1112 | 0.3297 |
Loa Loa (eye worm) | hypothetical protein | 0.008 | 0.1112 | 0.154 |
Schistosoma mansoni | thyroid hormone receptor | 0.0164 | 0.2854 | 0.4258 |
Mycobacterium leprae | Probable phosphoglycerate kinase Pgk | 0.0189 | 0.3373 | 1 |
Trypanosoma cruzi | PAS-domain containing phosphoglycerate kinase, putative | 0.0069 | 0.0898 | 0.2663 |
Toxoplasma gondii | ABC1 family protein | 0.008 | 0.1112 | 0.3039 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.0891 um | PUBCHEM_BIOASSAY: Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 12.9953 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.